Mechanistically, we showed that Dll1+ tumor cells resist chemotherapy by avoiding drug-induced cell death and DNA damage as seen by cleaved-caspase-3 assay, γH2AX staining, TUNEL and cell cycle assays. Here, DLL1 is linked to neoplasm.